Cargando…

Small RNA sequencing to differentiate lung squamous cell carcinomas from metastatic lung tumors from head and neck cancers

Distinguishing lung squamous cell carcinoma (LSQCC) from a solitary metastatic lung tumor (MSQCC) from head and neck squamous cell carcinoma (HNSQCC) presents a difficult diagnostic challenge even after detailed pathological assessment. Treatment options and estimated survival outcomes after pulmona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimada, Yoshihisa, Matsubayashi, Jun, Saito, Akira, Ohira, Tatsuo, Kuroda, Masahiko, Ikeda, Norihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935561/ https://www.ncbi.nlm.nih.gov/pubmed/33668046 http://dx.doi.org/10.1371/journal.pone.0248206

Ejemplares similares

Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
por: Shimada, Yoshihisa, et al.
Publicado: (2021)

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification
por: Shimada, Yoshihisa, et al.
Publicado: (2013)

Ubiquitin C‐terminal hydrolase‐L1 has prognostic relevance and is a therapeutic target for high‐grade neuroendocrine lung cancers
por: Shimada, Yoshihisa, et al.
Publicado: (2020)

Retrospective Analysis of Nodal Spread Patterns According to Tumor Location in Pathological N2 Non-small Cell Lung Cancer
por: Shimada, Yoshihisa, et al.
Publicado: (2012)

Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma
por: Shimada, Yoshihisa, et al.
Publicado: (2023)

Cytological differences between invasive and noninvasive or minimally invasive lung adenocarcinomas diagnosed in Japanese patients using needle biopsy specimens of pulmonary lesions ≤3 cm in diameter
por: Matsubayashi, Jun, et al.
Publicado: (2019)

Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening
por: Suda, Kenichi, et al.
Publicado: (2023)

Ruptured mediastinal mature teratoma causing severe mediastinitis: report of a surgically resected case and a literature review
por: Ota, Eri, et al.
Publicado: (2021)

Correction: Ruptured mediastinal mature teratoma causing severe mediastinitis: report of a surgically resected case and a literature review
por: Ota, Eri, et al.
Publicado: (2023)

Segmentectomy for clinically early‐stage primary squamous cell carcinoma of the lung
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Tumor volume determines the feasibility of cell‐free DNA sequencing for mutation detection in non‐small cell lung cancer
por: Ohira, Tatsuo, et al.
Publicado: (2016)

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer
por: Tsutani, Yasuhiro, et al.
Publicado: (2021)

Performance of Oncomine Fusion Transcript kit for formalin‐fixed, paraffin‐embedded lung cancer specimens
por: Sakai, Kazuko, et al.
Publicado: (2019)

Investigation of EGFR mutations in non-small cell lung cancer usually undetectable by PCR methods
por: Matsubara, Taisuke, et al.
Publicado: (2022)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization
por: Polo, Valentina, et al.
Publicado: (2016)

Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema
por: Mimae, Takahiro, et al.
Publicado: (2016)

Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer
por: Shimada, Yoshihisa, et al.
Publicado: (2023)

A gene expression profile test to resolve head & neck squamous versus lung squamous cancers
por: Lal, Anita, et al.
Publicado: (2013)

F-18 fluorodeoxyglucose uptake in lymph nodes and sonographic features on endobronchial ultrasonography predict lymph node metastasis in lung cancer patients
por: Yamamichi, Takashi, et al.
Publicado: (2020)

Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer
por: Samejima, Joji, et al.
Publicado: (2021)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness
por: Mimae, Takahiro, et al.
Publicado: (2022)

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer
por: Ang, Yvonne LE, et al.
Publicado: (2016)

Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Metastatic Squamous Cell Carcinoma of the Lung Disclosed From Constipation Workup
por: Lin, Zilan X., et al.
Publicado: (2023)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
por: Pivot, X, et al.
Publicado: (2001)

Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma
por: Mokhtari, Sepideh
Publicado: (2012)

Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
por: Lorch, Jochen H
Publicado: (2009)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Sukari, Ammar, et al.
Publicado: (2015)

Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
por: Guenne, Clémence, et al.
Publicado: (2014)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Argiris, Athanassios, et al.
Publicado: (2017)

Socioeconomic factors and survival in patients with non‐metastatic head and neck squamous cell carcinoma
por: Xu, Cheng, et al.
Publicado: (2017)

Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022)

KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer
por: Chen, Hao, et al.
Publicado: (2023)

Selectively high efficacy of eribulin against high-grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck
por: Kobayashi, Yutaka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_97bf5ut5d20ho6kjmj1eqatj8f